Skip to main content

Hidradenitis Suppurativa

Hidradenitis Suppurativa

Featured

Derm Q&A
Findings from a recent study showed patients with HS have a similar incidence to other well-studied, at-risk patient groups of opioid use, including those with newly diagnosed musculoskeletal pain. Lead study author Sarah Reddy discusses the implications of these findings and the role dermatologists play in identifying patients at-risk for opioid misuse.
News
Findings from a recent study showed major depressive disorder was associated with an increased risk of autoimmune skin diseases, including hidradenitis suppurativa.
News
Findings from a recent study indicated that several comorbidities precede a diagnosis of hidradenitis suppurativa, and that several develop afterwards.
News
Findings from an open label cohort study showed treatment of moderate to severe hidradenitis suppurativa with an IL-17 inhibitor was associated clinical response and had a favorable safety profile.
News
Findings from a recent study showed a potential association between birth weight and childhood weight and the risk of developing hidradenitis suppurativa in adulthood.
Back to Top